Crucell Gets NIH Pact
Vaccine developer Crucell (CRXL) received a $16.2 million contract from the National Institutes of Health's allergy and infectious disease group to develop an HIV vaccine.
Through the contract, Crucell will be collaborating with Charles River Laboratories (CRL) and the Beth Israel Deaconess Medical Center at Harvard Medical School. The program will also be supported by the National Institute of Allergy and Infectious Diseases Vaccine Research Center.
"We are very grateful to the NIAID for their support and ongoing endorsement of our technology in the field of HIV vaccine development," said Crucell's chief scientific officer, Dr. Jaap Goudsmit, in a press release Monday. "Multiple high-level vaccine initiatives are essential if we are to be successful in delivering the safe, effective and accessible HIV vaccine that the world needs so urgently."
Shares of Crucell were up 2.3% to $23.70.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV